Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers

Recurrent/metastatic (R/M) head and neck cancers bear a poor prognosis. In this analysis, we examined the efficacy and the outcome of targeted therapy recommendations based on the patients’ molecular tumor portrait after failure of all standard therapy options. In this single-center, real-world retr...

Full description

Bibliographic Details
Main Authors: Hossein Taghizadeh, Robert M. Mader, Leonhard Müllauer, Thorsten Fuereder, Alexandra Kautzky-Willer, Gerald W. Prager
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
metastatic and recurrent head and neck cancers
targeted therapy
molecular profiling
time to treatment failure
turnaround time
immunohistochemistry
Online Access:https://www.mdpi.com/2072-6694/12/11/3381

Internet

https://www.mdpi.com/2072-6694/12/11/3381

Similar Items